| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.42 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |